PriceTargets.com logo

Pulse Biosciences - PLSE Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $22.00
  • Forecasted Upside: 65.79%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$13.27 As of 12/4/2025 05:00 PM ET
▼ -0.22 (-1.63%)

This chart shows the closing price for PLSE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Pulse Biosciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PLSE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PLSE

Analyst Price Target is $22.00
▲ +65.79% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Pulse Biosciences in the last 3 months. The average price target is $22.00, with a high forecast of $22.00 and a low forecast of $22.00. The average price target represents a 65.79% upside from the last price of $13.27.

This chart shows the closing price for PLSE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 2 contributing investment analysts is to hold stock in Pulse Biosciences. This rating has held steady since September 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
7/7/2025OppenheimerInitiated CoverageOutperform$22.00
9/21/2022Maxim GroupDowngradeBuy ➝ Hold
5/13/2022HC WainwrightDowngradeBuy ➝ Neutral
5/12/2022StephensDowngradeOverweight ➝ Equal Weight
4/1/2022Maxim GroupInitiated CoverageBuy$13.00
4/1/2022StephensLower TargetOverweight$14.00 ➝ $12.00
4/1/2022HC WainwrightLower TargetBuy$20.00 ➝ $8.50
2/10/2022HC WainwrightLower TargetBuy$43.00 ➝ $20.00
11/16/2021HC WainwrightLower TargetBuy$46.00 ➝ $43.00
8/10/2021HC WainwrightReiterated RatingBuy$46.00
7/26/2021StephensInitiated CoverageOverweight$28.00
3/11/2021Maxim GroupInitiated CoverageBuy$40.00
2/4/2021HC WainwrightBoost TargetBuy$40.00 ➝ $46.00
1/26/2021HC WainwrightBoost TargetBuy$16.00 ➝ $40.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.07 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2025
  • 11 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 3 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 0 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 0 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Pulse Biosciences logo
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Read More

Today's Range

Now: $13.27
Low: $13.16
High: $13.54

50 Day Range

MA: $16.18
Low: $12.66
High: $19.94

52 Week Range

Now: $13.27
Low: $12.56
High: $25.00

Volume

178,210 shs

Average Volume

171,476 shs

Market Capitalization

$899.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.8

Frequently Asked Questions

What sell-side analysts currently cover shares of Pulse Biosciences?

The following equities research analysts have issued reports on Pulse Biosciences in the last year: Oppenheimer Holdings, Inc., Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for PLSE.

What is the current price target for Pulse Biosciences?

0 Wall Street analysts have set twelve-month price targets for Pulse Biosciences in the last year. Their average twelve-month price target is $22.00, suggesting a possible upside of 65.8%. Oppenheimer Holdings, Inc. has the highest price target set, predicting PLSE will reach $22.00 in the next twelve months. Oppenheimer Holdings, Inc. has the lowest price target set, forecasting a price of $22.00 for Pulse Biosciences in the next year.
View the latest price targets for PLSE.

What is the current consensus analyst rating for Pulse Biosciences?

Pulse Biosciences currently has 1 sell rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PLSE, but not buy more shares or sell existing shares.
View the latest ratings for PLSE.

What other companies compete with Pulse Biosciences?

Other companies that are similar to Pulse Biosciences include LivaNova, Envista, Liquidia, Soleno Therapeutics and National Vision. Learn More about companies similar to Pulse Biosciences.

How do I contact Pulse Biosciences' investor relations team?

Pulse Biosciences' physical mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company's listed phone number is (510) 906-4600 and its investor relations email address is [email protected]. The official website for Pulse Biosciences is www.pulsebiosciences.com. Learn More about contacing Pulse Biosciences investor relations.